TIPIRACIL\TRIFLURIDINE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 147 adverse event reports in the FDA FAERS database where TIPIRACIL\TRIFLURIDINE was used for Neoplasm malignant.
Most Reported Side Effects for TIPIRACIL\TRIFLURIDINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,017 | 29.4% | 3,013 | 197 |
| Disease progression | 1,774 | 17.3% | 831 | 388 |
| Fatigue | 1,298 | 12.7% | 197 | 335 |
| Nausea | 1,135 | 11.1% | 172 | 335 |
| Diarrhoea | 965 | 9.4% | 111 | 321 |
| Decreased appetite | 659 | 6.4% | 105 | 216 |
| Vomiting | 628 | 6.1% | 93 | 277 |
| White blood cell count decreased | 483 | 4.7% | 49 | 202 |
| Asthenia | 472 | 4.6% | 104 | 228 |
| Anaemia | 388 | 3.8% | 76 | 183 |
| Neutropenia | 370 | 3.6% | 53 | 127 |
| Drug ineffective | 361 | 3.5% | 33 | 41 |
| Constipation | 322 | 3.1% | 42 | 115 |
| Dehydration | 318 | 3.1% | 41 | 249 |
| Abdominal pain | 313 | 3.1% | 43 | 134 |
Other Indications for TIPIRACIL\TRIFLURIDINE
Colon cancer (4,053)
Colorectal cancer metastatic (1,320)
Rectal cancer (1,297)
Product used for unknown indication (811)
Colorectal cancer (404)
Colon cancer metastatic (370)
Rectosigmoid cancer (263)
Gastric cancer (171)
Adenocarcinoma of colon (135)
Rectal cancer metastatic (132)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)